“Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan”. Physical Education, Health and Social Sciences, vol. 4, no. 1, Feb. 2026, pp. 129-36, https://doi.org/10.63163/jpehss.v4i1.1040.